NCT01401309

Brief Summary

This study is to examine if there is improved sensitivity in detecting hepatic lesions using respiratory gating and if there is an improvement in confidence defining lesions as benign or malignant.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2011

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

January 24, 2011

Completed
6 months until next milestone

First Posted

Study publicly available on registry

July 25, 2011

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2011

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2013

Completed
Last Updated

February 21, 2014

Status Verified

February 1, 2014

Enrollment Period

10 months

First QC Date

January 24, 2011

Last Update Submit

February 20, 2014

Conditions

Colon Cancer

Outcome Measures

Primary Outcomes (1)

  • Detecting

    To exam if there is an improved sensitivity in detecting hepatic lesions using respiratory gating and if there is improvement in confidence defining lesions as benign or malignant

    Jan 2011 - Nov 2011

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with colon cancer

You may qualify if:

  • Patients with colon cancer
  • years or older
  • Signed Informed Consent Form
  • Blood Glucose of 200 or less prior to scan

You may not qualify if:

  • Patients with known hepatic metastasis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cancer Treamtent Centers of America at Southwestern Regional Medical Center, Inc

Tulsa, Oklahoma, 74133, United States

Location

MeSH Terms

Conditions

Colonic Neoplasms

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 24, 2011

First Posted

July 25, 2011

Study Start

January 1, 2011

Primary Completion

November 1, 2011

Study Completion

March 1, 2013

Last Updated

February 21, 2014

Record last verified: 2014-02

Locations

US(1)